Human ECM for devices and therapeutics

Gail Naughton, Robert S Kellar

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Some of the views on a human extracellular matrix (hECM) materials, which is manufactured to mimic characteristics of the embryonic environment, are discussed. The hECM is developed through a tissue-engineering technology using neonatal fibroblasts to create a nonsoluble matrix materials, similar to the embryonic structural tissue that provide the framework for development of blood, skin, muscle, and bone. Human ECM does not carry any risk of an allergic reaction or the transmission of animal viruses. It can be used as a coating for implants to improve tissue ingrowth, vehicles for cell delivery, injectables for soft-tissue augmentation, and tissue regeneration patches. The production of the hECM can be encourage by exploring growing neonatal fibroblasts under fetal-like conditions. This material is a by-product of the culture process and is being evaluated for a variety of clinical and research use.

Original languageEnglish (US)
Pages (from-to)102-109
Number of pages8
JournalMedical Device and Diagnostic Industry
Volume30
Issue number5
StatePublished - May 2008
Externally publishedYes

Fingerprint

Military electronic countermeasures
Fibroblasts
Tissue
Tissue regeneration
Engineering technology
Viruses
Tissue engineering
Byproducts
Muscle
Skin
Bone
Animals
Blood
Coatings

ASJC Scopus subject areas

  • Bioengineering

Cite this

Human ECM for devices and therapeutics. / Naughton, Gail; Kellar, Robert S.

In: Medical Device and Diagnostic Industry, Vol. 30, No. 5, 05.2008, p. 102-109.

Research output: Contribution to journalArticle

@article{bad780c253cb476199f7c3a2533628ec,
title = "Human ECM for devices and therapeutics",
abstract = "Some of the views on a human extracellular matrix (hECM) materials, which is manufactured to mimic characteristics of the embryonic environment, are discussed. The hECM is developed through a tissue-engineering technology using neonatal fibroblasts to create a nonsoluble matrix materials, similar to the embryonic structural tissue that provide the framework for development of blood, skin, muscle, and bone. Human ECM does not carry any risk of an allergic reaction or the transmission of animal viruses. It can be used as a coating for implants to improve tissue ingrowth, vehicles for cell delivery, injectables for soft-tissue augmentation, and tissue regeneration patches. The production of the hECM can be encourage by exploring growing neonatal fibroblasts under fetal-like conditions. This material is a by-product of the culture process and is being evaluated for a variety of clinical and research use.",
author = "Gail Naughton and Kellar, {Robert S}",
year = "2008",
month = "5",
language = "English (US)",
volume = "30",
pages = "102--109",
journal = "Medical Device and Diagnostic Industry",
issn = "0194-844X",
publisher = "Canon Communications LLC",
number = "5",

}

TY - JOUR

T1 - Human ECM for devices and therapeutics

AU - Naughton, Gail

AU - Kellar, Robert S

PY - 2008/5

Y1 - 2008/5

N2 - Some of the views on a human extracellular matrix (hECM) materials, which is manufactured to mimic characteristics of the embryonic environment, are discussed. The hECM is developed through a tissue-engineering technology using neonatal fibroblasts to create a nonsoluble matrix materials, similar to the embryonic structural tissue that provide the framework for development of blood, skin, muscle, and bone. Human ECM does not carry any risk of an allergic reaction or the transmission of animal viruses. It can be used as a coating for implants to improve tissue ingrowth, vehicles for cell delivery, injectables for soft-tissue augmentation, and tissue regeneration patches. The production of the hECM can be encourage by exploring growing neonatal fibroblasts under fetal-like conditions. This material is a by-product of the culture process and is being evaluated for a variety of clinical and research use.

AB - Some of the views on a human extracellular matrix (hECM) materials, which is manufactured to mimic characteristics of the embryonic environment, are discussed. The hECM is developed through a tissue-engineering technology using neonatal fibroblasts to create a nonsoluble matrix materials, similar to the embryonic structural tissue that provide the framework for development of blood, skin, muscle, and bone. Human ECM does not carry any risk of an allergic reaction or the transmission of animal viruses. It can be used as a coating for implants to improve tissue ingrowth, vehicles for cell delivery, injectables for soft-tissue augmentation, and tissue regeneration patches. The production of the hECM can be encourage by exploring growing neonatal fibroblasts under fetal-like conditions. This material is a by-product of the culture process and is being evaluated for a variety of clinical and research use.

UR - http://www.scopus.com/inward/record.url?scp=45749128610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45749128610&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:45749128610

VL - 30

SP - 102

EP - 109

JO - Medical Device and Diagnostic Industry

JF - Medical Device and Diagnostic Industry

SN - 0194-844X

IS - 5

ER -